Search Results - "Ceballos, Isaac"
-
1
TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck
Published in Frontiers in oncology (01-08-2023)“…ObjectivesThe aim of this study was to confirm the efficacy of the ERBITAX scheme (paclitaxel 80 mg/m2 weekly and cetuximab 400 mg/m2 loading dose, and then…”
Get full text
Journal Article -
2
Anti-drug antibodies anti-trastuzumab in the treatment of breast cancer
Published in Journal of oncology pharmacy practice (01-08-2021)“…Introduction Trastuzumab is a monoclonal antibody which could induce the activation of a humoral immune response generating anti-drug antibodies (ADAs). Such…”
Get full text
Journal Article -
3
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
Published in Cancers (29-10-2021)“…The PANGEA-Breast trial evaluated a new chemo-immunotherapeutic combination that would synergistically induce long-term clinical benefit in HER2-negative…”
Get full text
Journal Article -
4
GEINOFOTE: Safety and activity analysis of the use of fotemustine (FT) in different schedules in progressive high-grade glioma (HGG) in Spain
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
5
Application of electric vehicles for primary frequency regulation service
Published in 2021 IEEE PES Innovative Smart Grid Technologies Conference - Latin America (ISGT Latin America) (15-09-2021)“…In the electricity system, the frequency behavior is an indicator of the quality of the service provider that expresses the equilibrium between the supply and…”
Get full text
Conference Proceeding -
6
Elderly glioblastoma patients: Survival analysis according adjuvant therapy and tumor molecular analysis
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e14046 Background: Glioblastoma (GBM) grade IV represents the most frequent and aggressive primary brain tumor. Despite complete surgical…”
Get full text
Journal Article -
7
Impact of surgery versus other treatment options in recurrent glioblastoma. Analysis of the Spanish Group of Neurooncology Research (GEINO) RETSINE database
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e14047 Background: Glioblastoma (GBM) is the most common brain primary tumor. Almost all patients have recurrent disease after initial treatment…”
Get full text
Journal Article -
8
Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients
Published in The Annals of pharmacotherapy (01-08-2020)“…Background: Subcutaneous trastuzumab (T-SC) administration does not allow the historical target concentration of 20 µg/mL for efficacy to be reached, from the…”
Get full text
Journal Article -
9
Influence of Anthropometric Characteristics in Patients With Her2-Positive Breast Cancer on Initial Plasma Concentrations of Trastuzumab
Published in The Annals of pharmacotherapy (01-11-2017)“…Background: Plasma concentrations of trastuzumab <20 µg/mL in patients with gastric cancer are associated with reduced progression-free and overall survival…”
Get full text
Journal Article -
10
Analysis of KRAS and NRAS mutations in 126 patients with KRAS exon 2 wild type for metastatic colorectal cancer (mCRC) in a single institution
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article